Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03012932 · ClinicalTrials.gov registry record · NA
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03012932 is a NA study that has completed, run by University of Miami. The registered enrollment target is 10 participants.
The verdict
NCT03012932, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The proposed study will examine the implementation of a Human Papilloma Virus (HPV) self-sampling intervention for under screened LBQ women living in South Florida. The study will enroll participants to receive the self-sampling intervention in community venues. The purpose of this study is to pilot the self-sampler for feasibility and acceptability within this underserved population.
Interventions
- BEHAVIORAL HPV self-sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-02-02 |
| Est. Completion | 2018-03-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03012932
The ClinicalTrials.gov registry entry for NCT03012932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HPV self-sampling is the first listed.
NCT03012932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03012932 about?
NCT03012932 is a clinical study titled "HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women". The proposed study will examine the implementation of a Human Papilloma Virus (HPV) self-sampling intervention for under screened LBQ women living in South Florida. The study will enroll participants to receive the self-sampling intervention in community venues. The purpose of this study is to pilot...
What is the current status of trial NCT03012932?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-02-02. Estimated completion is 2018-03-24.
What interventions are being tested in trial NCT03012932?
The interventions under investigation include: HPV self-sampling (BEHAVIORAL).
Who is sponsoring clinical trial NCT03012932?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.